Literature DB >> 1474953

Activation of oncogenes and/or inactivation of anti-oncogenes by reactive oxygen species.

H Wei1.   

Abstract

Abundant evidence indicates that reactive oxygen species (ROS) are involved in mutagenesis and carcinogenesis. These chemical-generated or phagocyte-released ROS are known to cause a variety of genetic alterations which lie at the heart of the carcinogenic process. ROS have also been shown to cause malignant transformation of normal cells, and to increase expression of certain proto-oncogenes such as c-fos and c-jun. It is known that certain proto-oncogenes and anti-oncogenes may serve as the targets of carcinogens of various sorts. I hypothesize that ROS-mediated DNA damage may cause mutations and/or deletions in certain specific coding regions of tumor-related genes, and could be responsible for subsequent activation of oncogenes and/or inactivation of anti-oncogenes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1474953     DOI: 10.1016/0306-9877(92)90120-2

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

1.  Associations between SNPs within antioxidant genes and the risk of prostate cancer in the Siberian region of Russia.

Authors:  N A Oskina; N A Еrmolenko; U A Boyarskih; A F Lazarev; V D Petrova; D I Ganov; O G Tonacheva; G I Lifschitz; M L Filipenko
Journal:  Pathol Oncol Res       Date:  2014-03-09       Impact factor: 3.201

2.  Inhibition of astrocyte glutamate uptake by reactive oxygen species: role of antioxidant enzymes.

Authors:  O Sorg; T F Horn; N Yu; D L Gruol; F E Bloom
Journal:  Mol Med       Date:  1997-07       Impact factor: 6.354

Review 3.  In Vivo Imaging with Genetically Encoded Redox Biosensors.

Authors:  Alexander I Kostyuk; Anastasiya S Panova; Aleksandra D Kokova; Daria A Kotova; Dmitry I Maltsev; Oleg V Podgorny; Vsevolod V Belousov; Dmitry S Bilan
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

4.  Reactive oxygen species: role in the development of cancer and various chronic conditions.

Authors:  Gulam Waris; Haseeb Ahsan
Journal:  J Carcinog       Date:  2006-05-11

5.  γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.

Authors:  Timothy T Bui; Ryan T Nitta; Suzana A Kahn; Seyed-Mostafa Razavi; Maya Agarwal; Parvir Aujla; Sharareh Gholamin; Lawrence Recht; Gordon Li
Journal:  BMC Cancer       Date:  2015-04-07       Impact factor: 4.430

6.  Organoids Increase the Predictive Value of in vitro Cancer Chemoprevention Studies for in vivo Outcome.

Authors:  Rose N Njoroge; Rajita J Vatapalli; Sarki A Abdulkadir
Journal:  Front Oncol       Date:  2019-02-20       Impact factor: 6.244

7.  A novel methylated analogue of L-Mimosine exerts its therapeutic potency through ROS production and ceramide-induced apoptosis in malignant melanoma.

Authors:  Sotiris Kyriakou; William Cheung; Theodora Mantso; Melina Mitsiogianni; Ioannis Anestopoulos; Stephany Veuger; Dimitris T Trafalis; Rodrigo Franco; Aglaia Pappa; David Tetard; Mihalis I Panayiotidis
Journal:  Invest New Drugs       Date:  2021-02-23       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.